We studied two brothers with hereditary xanthinuria (xanthine oxidase deficiency) and their family members. The two brothers had extremely low concentrations of urate but markedly high concentrations of xanthine and hypoxanthine in plasma and urine. Xanthine oxidase activities were virtually absent in the duodenal mucosa. In their parents (presumed obligate heterozygotes), the activities of xanthine oxidase were about half that of normal subjects. Although plasma xanthine and hypoxanthine concentrations of the parents were normal, urinary xanthine and hypoxanthine excretions were significantly higher than those of normal subjects (xanthine, father 17.1 mg/g creatinine and mother 27.4 vs. normal controls 5.7 to 11.0; hypoxanthine, father 14.0 and mother 27.3 vs. controls 4.0 to 8.4). Similar changes in the metabolite concentrations were seen in at least 6 other re1 atives, suggesting they were heterozygotes. This study indicates that the presumed obligate heterozygotes of xanthine oxidase deficiency retained about half normal enzyme activities causing the partial metabolic blockage in vivo at this enzyme step.
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---CTP RATIO AND CYTOTOXIC EFFECT OF ARA-C 72 HAJIME KAWASAKI, MAsAMuNE HIGAsHIGAwA, TosHIKI OOKUBO. HITOSHI KAMIYA, and MINORU SAKURAI. The dcT~/ara-CTP ratio seem to be one of very important factors in ara-C cytotoxicity. In confirmation of this hypothesis, we studied relations between cell growth and ratio of d c~~1 a r -a -C T P in R.1.1. mice splenic cells, CCRF-CEM human T cell leukemic cells and ML-1 human myelogenous leukemic cells. (Method) Intracellular acidsoluble nucleotide were extracted with TCA, then neutralized with Freon and Amine. After periodate oxidation, deoxy-ribonucleotide were obtained. Intracellular ara-CTP and deoxy-ribonucleotide pools were analyzed by the HPLC method. (Result and Discussion) Growth of R.1.1. cells was inhibitted a t concentration up t o luM of ara-C. Intra-cellular dCTP and ara-CTP level in the R.1.1. cells exposure to luM of ara-C were 56.0 and 48.0pmo1/1 06cells, respectively, whereas exposure to lOuM of ara-C, intra-cellular dCTP and ara-CTP level were 44.0, 351 .Opmol/ 1 06cells, respectively. At the higher level of ara-CTP than o f dCTP, ara-C significantly effected on the growth of R.1.1. cells. Sarne relation was shown in CCRF-CEM cells and ML-1 cells. These data suggested that ara-C had significant effects on the growth of cells at the higher level of ara-CTP than of dCTP. So the dCTP/ara-CTP ratio is one of very important factors in ara-C cytotoxicity. 
--
Tatibana. Chlba University School of Medicine. Dept. of Biochemistry, Inohana, Chiba 280, Japan. Phosphoribosylpyrophosphate (PRPP), an important substrate in the synthesis of purine, pyrimidine and pyridlne nucleotides, is synthesized by the catalysis of PRPP synthetase. The enzyme from human erythrocytes exists as various associated forms and is sub2ect to complex regulation. However, the in situ regulation of PRPP synthesis is poorly understood. As an approach to the problem, we purified rat liver PRPP synthetase and partially characterized the complex physical nature of the enzyme. It was purified to a specific activity of 7.28 Umol/min/mg, the highest value so far reported for a mammalian enzyme, but still contained several components of 34 kDa, 38 kDa and 40 kDa in relative amounts of that order. In various usual chromatographies, these components were coeluted, suggesting that the heterogeneous aggregate is the native form of the enzyme. To identify the catalytic subunit, the enzyme was subjected to gel filtration on TSK GZOOOSW in 1 M MgC12, an agent to dissociate proteins. The enzyme appeared as a 68 kDa peak and the last quarter of the fractions contained only the 34 kDa species, wlth a definite catalytic activity. Other components in the aggregate appear to exert suppressive effects on the activity. Sequence analyses of N-terminal region and two tryptic peptides of the 34 kDa subunit, together wlth our cDNA cloning experiments (J.Biol.Chem., 262, 14867. 1987) . revealed that the 34 kDa component consists of two homologous isoforms (PRS I and 11).
EXERCISE-INDUCED ALTERATION OF ERYTIiROCYTE GLYCOLYSIS

V C
ASSOCIATED WITH HYOGENIC HYPERURICEMIA
13
Norio Kono, Takao Myogenic hyperuricpmia is caused by increased production of uric acid secondar:~ to enhanced release of inosine and hypoxanthine from exercising muscles into blood. This novel mechanism is evident in glycogenosis types VII (muscle phosphofructokinase deficiency), I11 (debranching enzyme deficiency), and V. In this study, we examined the effect of muscular exercise on the glyco1:rsis of circulating erythrocytes in glycogenosis types VII and 111. The concentratinn of erythrocyte 2.3-bisphosphoglycerate, which had decreaspd because of genetic partial deficiency of erythrocyt~ phosphofructnkinase, was further decreased after prolonged bed rest in patients with type VII. Ergometric exercise rapidly increased fructose-1,6-P2
, dihydroxyacetone-P plus glyceraldehyde-3-P, and 2,3-bisphosphoglycerate in circulating erythrocytes. Similar changes werr observed after ~xercise in patipnts with type 111. The exerciseinduced metabolic alteration of erythrocytes was reproduced in vitro by incubating normal erythrocytes in the presence of inosine. We conclude that physical activity affects glycolysis in erythrocytes in glycogenosis types VII and 111, and that myogenic factors including inosine are respolsibl~ for this change.
ISOLATION AND CIIARACTERIZATION OF HELA CELL MUTANTS RESISTANT TO AN ADENINE ANALOG 4-
76 CARBAMOYLIMIDAZOLIUM-5 ' -0LATE (CIO) . Siideki , ., Kovama, Atsuko Tamura, Masa-aki Wachi, and Michio Matsubshi. Kihara Inst. Biol. Res., Yokohama City Univ., Yokohama, and Inst. Applied Microbiol., Univ. Tokyo, Tokyo, Japan.
It is known that CIO is metabolized into bredinin-5'-monophosphate (Brd-MP) by adenine phosphoribosyltransferase (APRT) and that this metabolite is a specific inhibitor of IMP dehydrogenase. We have reported that mouse cell mutants resistant to the cytotoxicity of CIO have lost the enzyme activity (Cancer Res., 42, 4210, 1982) . Recently, we isolated the same type of resistant mutants from mutagenized NeLa cells. In contrast, the HeLa cell mutants had a normal level of APRT and were cross-resistant to bredinin, a ribosylated form of CIO, but not to mycophenolic acid and virazole. These mutants showed a normal level of IMP dehydrogenase and the sensitivity to Brd-MP of the parental and mutant cell enzymes were similar. The mutants gradually reduced its resistance after passage without the p u g for more than 2 months. We also found that in 10 g supernatants prepared from the mutants there existed a 28 k protein by SDS polyacrylamide gel electrophoresis and its amount was proportional to the degree of the resistance. These results suggest that this protein should be involved in the resistance observed in the lleLa cell mutants.
